Bristol Hematology - Oncology Centre

Bristol BS2 8ED

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Multiple Myeloma, Myelodysplastic Syndromes

Studies at this site

• A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early